Safety of continued administration of enzalutamide in patients with prostate cancer who showed benefit from prior exposure: A phase 2 open-label extension study.

@inproceedings{Lam2018SafetyOC,
  title={Safety of continued administration of enzalutamide in patients with prostate cancer who showed benefit from prior exposure: A phase 2 open-label extension study.},
  author={Elaine T Lam and Russell Z. Szmulewitz and Leonard Joseph Appleman and Anthony William Tolcher and Andrew Peter Krivoshik and Beno{\^i}t Baron and Niel Malan and Vitalii Ghicav{\^i}i},
  year={2018}
}

Topics from this paper.

Similar Papers

Loading similar papers…